Processing

Please wait...

Settings

Settings

Goto Application

1. WO1997038981 - NOVEL $g(a)-HYDROXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND USE

Publication Number WO/1997/038981
Publication Date 23.10.1997
International Application No. PCT/EP1997/001688
International Filing Date 04.04.1997
Chapter 2 Demand Filed 11.09.1997
IPC
C07D 217/22 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
217Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
22with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
C07D 239/34 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
239Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
02not condensed with other rings
24having three or more double bonds between ring members or between ring members and non-ring members
28with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
32One oxygen, sulfur or nitrogen atom
34One oxygen atom
C07D 239/48 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
239Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
02not condensed with other rings
24having three or more double bonds between ring members or between ring members and non-ring members
28with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
46Two or more oxygen, sulfur or nitrogen atoms
48Two nitrogen atoms
C07D 239/52 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
239Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
02not condensed with other rings
24having three or more double bonds between ring members or between ring members and non-ring members
28with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
46Two or more oxygen, sulfur or nitrogen atoms
52Two oxygen atoms
C07D 239/56 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
239Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
02not condensed with other rings
24having three or more double bonds between ring members or between ring members and non-ring members
28with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
46Two or more oxygen, sulfur or nitrogen atoms
56One oxygen atom and one sulfur atom
C07D 239/60 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
239Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
02not condensed with other rings
24having three or more double bonds between ring members or between ring members and non-ring members
28with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
46Two or more oxygen, sulfur or nitrogen atoms
60Three or more oxygen or sulfur atoms
CPC
A61P 13/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
A61P 13/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
13Drugs for disorders of the urinary system
12of the kidneys
A61P 5/42
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
5Drugs for disorders of the endocrine system
38of the suprarenal hormones
42for decreasing, blocking or antagonising the activity of mineralocorticosteroids
A61P 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
A61P 9/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
10for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
C07D 217/22
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
217Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
22with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
Applicants
  • BASF AKTIENGESELLSCHAFT [DE]/[DE] (AllExceptUS)
  • KLINGE, Dagmar [DE]/[DE] (UsOnly)
  • AMBERG, Wilhelm [DE]/[DE] (UsOnly)
  • BAUMANN, Ernst [DE]/[DE] (UsOnly)
  • KLING, Andreas [DE]/[DE] (UsOnly)
  • RIECHERS, Hartmut [DE]/[DE] (UsOnly)
  • UNGER, Liliane [DE]/[DE] (UsOnly)
  • RASCHACK, Manfred [DE]/[DE] (UsOnly)
  • HERGENRÖDER, Stefan [DE]/[DE] (UsOnly)
  • SCHULT, Sabine [DE]/[DE] (UsOnly)
Inventors
  • KLINGE, Dagmar
  • AMBERG, Wilhelm
  • BAUMANN, Ernst
  • KLING, Andreas
  • RIECHERS, Hartmut
  • UNGER, Liliane
  • RASCHACK, Manfred
  • HERGENRÖDER, Stefan
  • SCHULT, Sabine
Common Representative
  • BASF AKTIENGESELLSCHAFT
Priority Data
196 14 533.312.04.1996DE
Publication Language German (DE)
Filing Language German (DE)
Designated States
Title
(DE) NEUE $g(a)-HYDROXYSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG
(EN) NOVEL $g(a)-HYDROXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND USE
(FR) NOUVEAUX DERIVES D'ACIDE $g(a)-HYDROXYLIQUE, LEUR PREPARATION ET LEUR UTILISATION
Abstract
(DE)
Die vorliegende Erfindung betrifft Carbonsäurederivate der Formel (I), wobei die Reste die in der Beschreibung angegebene Bedeutung besitzen, die Herstellung dieser Verbindungen und ihre Verwendung als Arzneimittel.
(EN)
The present invention relates to carboxylic acid derivatives of the formula (I) in which the radicals have the meaning given in the description, the production of these compounds and their use as medicaments.
(FR)
L'invention concerne des dérivés d'acide carboxylique de la formule (I) dans laquelle les radicaux correspondent à la définition donnée dans la description. L'invention concerne également la préparation de ces composés et leur utilisation comme médicaments.
Latest bibliographic data on file with the International Bureau